Literature DB >> 6455764

Pathogenic mechanisms in primary biliary cirrhosis.

H C Thomas, O Epstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6455764     DOI： 10.1007/bf02054111

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  52 in total

1.  Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

Review 2.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

3.  Chronic cutaneous graft-versus-host disease in man.

Authors:  H M Shulman; G E Sale; K G Lerner; E A Barker; P L Weiden; K Sullivan; B Gallucci; E D Thomas; R Storb
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

4.  Sjögren-type syndrome after allogeneic bone-marrow transplantation.

Authors:  A A Gratwohl; A A Gratwhol; H M Moutsopoulos; T M Chused; M Akizuki; R O Wolf; J B Sweet; A B Deisseroth
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

5.  A homeostatic mechanism for the removal of antigen from the portal circulation.

Authors:  H C Thomas; F Vaez-Zadeh
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

6.  A biological role for the major histocompatibility antigens.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

7.  Immune complexes in acute and chronic liver disease.

Authors:  H C Thomas; D De Villiers; B Potter; H Hodgson; S Jain; D P Jewell; S Sherlock
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

8.  Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.

Authors:  B J Potter; E Elias; H C Thomas; S Sherlock
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

9.  Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.

Authors:  C J Jaffe; J M Vierling; E A Jones; T J Lawley; M M Frank
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

10.  Sclerodermatous graft-versus-host disease limited to an area of measles exanthem.

Authors:  J R Fenyk; C M Smith; P I Warkentin; W Krivit; R W Goltz; J E Neely; M E Nesbit; N K Ramsay; P F Coccia; J H Kersey
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321
View more
  4 in total

Review 1.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

2.  T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.

Authors:  L Si; T L Whiteside; R R Schade; T E Starzl; D H Van Thiel
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

3.  The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis.

Authors:  H P Schultheiss; P Berg; M Klingenberg
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

4.  Inhibition of the adenine nucleotide translocator by organ specific autoantibodies in primary biliary cirrhosis.

Authors:  H P Schultheiss; P A Berg; M Klingenberg
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.